Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro is a research paper published in International Journal of Nanomedicine (2020). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA260449
NCI NIH HHS
Grant: R01 CA136494
NCI NIH HHS
Grant: R01 CA220237
NCI NIH HHS
Grant: R01 CA213278
National Institutes of Health
Grant: 5R01CA220237-02
UBAP2, A New Molecule in Pancreatic Cancer Progression
National Institutes of Health
Grant: 5R01CA213278-04
Reprogramming Tumor Microenvironment by Nanoparticle
National Institutes of Health
Grant: 5R01CA136494-04
Molecular mechanism of antiangiogenic properties of gold nanoparticle
FWCI
1.22
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals